To identify the downstream target(s) of EZH2 involved in prostate cancer progression, we explored the public EZH2 and histone H3K27me3 ChIP-seq (chromatin immunoprecipitation assays with sequencing) datasets of various prostate cancer cell lines [29]. This evidence concerns the gene EZH2 and prostate cancer.